Free Trial
OTCMKTS:TDLAF

TBG Diagnostics (TDLAF) Stock Price, News & Analysis

TBG Diagnostics logo
$0.04 -0.01 (-14.00%)
As of 09/7/2021

About TBG Diagnostics Stock (OTCMKTS:TDLAF)

Key Stats

Today's Range
$0.04
$0.13
50-Day Range
$0.04
$0.04
52-Week Range
$0.01
$0.13
Volume
3,200 shs
Average Volume
6,655 shs
Market Capitalization
$2.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in Taiwan and China. It provides ExProbe HLA and HPA kits for human leukocyte antigen (HLA) and human platelet antigens (HPA) allele genotyping, which uses real time polymerase chain reaction (PCR) techniques with sequence specific primers and probes; Morgan SSP HLA kits for determining HLA alleles using PCR techniques with sequence specific primers; HLAssure SBT HLA Kits for transplantation donor selection; and AccuType SBT analysis software to analyze sequences from all ab1 based files. The company also offers Morgan SSPal HLA Typing Analysis Software, a gel result interpretation software; HLA typing services that offer low to high resolution using PCR fragment analysis (SSP) and DNA sequencing (SBT); QPCR Q6000, a six-channel real time PCR instrument; QzNGS NGS that provides high resolution HLA genotyping; and COVID-19 testing kits. It serves clinical labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 is based in Greenslopes, Australia.

Receive TDLAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TBG Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

TDLAF Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
TBG Diagnostics Ltd.
See More Headlines

TDLAF Stock Analysis - Frequently Asked Questions

TBG Diagnostics' stock was trading at $0.0430 on January 1st, 2025. Since then, TDLAF stock has increased by 0.0% and is now trading at $0.0430.
View the best growth stocks for 2025 here
.

Shares of TDLAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:TDLAF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.33 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.38 million
Optionable
Not Optionable
Beta
-12.38
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:TDLAF) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners